ReviewCancer management and research2026

Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia.

Yong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.